97102 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum Purification, fragmentation
Anti-Galectin-9 antibodies and uses thereof
#302Direct selection of cells expressing high levels of heteromeric proteins using glutamine synthetase intragenic complementation vectors
#303Method for producing porous cellulose medium
#304Multispecific antibody platform and related methods
#305METHOD FOR PRODUCING PROTEIN INCLUDING k CHAIN VARIABLE REGION
#306Separation matrix
#307Protein for rapid, efficient capture of antigens
#308Separation of Triple-Light Chain Antibodies Using Cation Exchange Chromatography
#309DNA-binding domain of CRISPR system, non-fucosylated and partially fucosylated proteins, and methods thereof
#310CMV neutralizing antigen binding proteins
#311Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
#312Cell culture additives and their use for increased bioprotein production from cells
#313Antibody-like peptides for quantifying therapeutic antibodies
#314Method for enhancing humoral immune response
#315TREATMENT OF SEVERE COMMUNITY ACQUIRED PNEUMONIA
#316Methods for the production of therapeutic, diagnostic, or research antibodies
#317Bivalent bispecific antibody hybrid protein expression and preparation methods
#318IDENTIFICATION AND ISOLATION OF ANTIBODIES FROM WHITE BLOOD CELLS
#319Bispecific coupled antibody, preparation method and application thereof
#320ANTIBODIES
#321Methods of engineering surface charge for bispecific antibody production
#322Generating multispecific antibody mixtures and methods of uses thereof
#323Monoclonal antibody FnAb8 and application thereof
#324Multimodal anion exchange matrices
#325METHODS OF PRODUCING AND PURIFYING MATRIX-BINDING FUSION PROTEINS BY ION-EXCHANGE CHROMATOGRAPHY
#326METHODS FOR SEPARATING ISOFORMS OF MONOCLONAL ANTIBODIES
#327Method for purifying composition comprising antibodies with anionic polymer
#328METHOD FOR ENRICHING A PREPARATION OF IMMUNOGLOBULINS WITH ANTI RSV IMMUNOGLOBULINS AND PREPARATION ENRICHED IN THIS WAY
#329Antibodies that specifically bind PD-1 and methods of use
#330Compositions derived from Cohn fraction paste and use thereof
#331Humanized antibody for treating or preventing cognitive disorders, process for producing the same, and agent for treating or preventing cognitive disorders using the same
#332Separating agent for human serum-derived IgG polyclonal antibodies, and method for separating human serum-derived IgG polyclonal antibodies using same
#333Mutated immunoglobulin-binding polypeptides
#334IMPROVED PROTEIN SEPARATION IN ION EXCHANGE CHROMATOGRAPHY
#335Cyclophosphamide analogs for use as immunogens and assay conjugates for an immunoassay of cyclophosphamide and ifosfamide
#336IgG, IgA and IgM antibody preparations, method of making and method of use in treatment
#337Compositions comprising purified anti-abeta monoclonal antibodies
#338ANTI-IL-17A AND IL-17F CROSS REACTIVE ANTIBODY VARIANTS AND COMPOSITIONS COMPRISING AND METHODS OF MAKING AND USING SAME
#339Antigen-Binding Protein Directed Against Epitope in the CH1 Domain of Human IgG Antibodies
#340Antibody purification method
#341PROCESSES FOR PURIFYING PROTEINS FROM PLASMA
#342Methods and compositions comprising purified recombinant polypeptides
#343Compositions comprising purified recombinant IL-13 antibody
#344IgG stimulated remyelination of peripheral nerves
#345FORMULATIONS COMPRISING PD-1 BINDING PROTEINS AND METHODS OF MAKING THEREOF
#346Antibody for immunoassay and method for preparing same
#347Method of treatment comprising purified recombinant IL-13 antibody
#348Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
#349SEPARATION METHOD FOR FUCOSYLATED ANTIBODIES
#350Methods of generating antibodies
#351A Separation Matrix and a Method of Separating Antibodies
#352Specifically purified anti-presepsin antibody
#353Low-viscosity, high concentration evolocumab formulations and methods of making the same
#354Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#355Refolding process for antibody's fragments
#356USE OF ALPHA-TOXIN FOR TREATING AND PREVENTING STAPHYLOCOCCUS INFECTIONS
#357IMMUNOGLOBULIN-BINDING MODIFIED PROTEIN
#358ANTIBODY-BINDING PROTEIN HAVING REDUCED ANTIBODY-BINDING CAPACITY IN ACIDIC pH REGION
#359Detection of CHO-MIF contaminations
#360METHODS FOR USE OF MIXED MULTIFUNCTIONAL SURFACES FOR REDUCING AGGREGATE CONTENT IN PROTEIN PREPARATIONS
#361AFFINITY CHROMATOGRAPHY PURIFICATION WITH LOW CONDUCTIVITY WASH BUFFER
#362Method for the reduction of host cell proteins in affinity chromatography
#363Immunoglobulin constant region Fc receptor binding agents
#364Afucosylated protein, cell expressing said protein and associated methods
#365Subcutaneous anti-HLA-DR monoclonal antibody for treatment of hematologic malignancies
#366IMMUNOGLOBULIN PURIFICATION
#367Method for the reduction of viral titer in pharmaceuticals
#368Method and apparatus for antibody production and purification
#369Chromatography ligand
#370COMPOSITION ENRICHED IN ANTI-A AND/OR ANTI-B POLYCLONAL IMMUNOGLOBULINS FOR USE IN THE TREATMENT OF AUTOIMMUNE DISEASES OR POLYCYTHEMIA
#371Expression process
#372Method for inactivation/removal of coagulation factors by precipitation
#373Method to produce an immunoglobulin preparation with improved yield
#374ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY
#375USE OF DEXTRAN SULFATE TO ENHANCE PROTEIN A AFFINITY CHROMATOGRAPHY
#376Composition Enriched in Anti-A and /or Anti B Polyclonal Immunoglobulins
#377Method for protein purification
#378Separation method
#379Agarose-filled ceramic apatite
#380METHOD OF REMOVING PROTEIN AGGREGATE
#381Use of alkaline washes during chromatography to remove impurities
#382Removal of serine proteases by treatment with finely divided silicon dioxide
#383METHOD FOR OBTAINING PEPTIDE FRAGMENT FROM ANTIBODY BY PROTEASE DECOMPOSITION REACTION WITH RESTRICTED REACTION FIELD
#384Purified antibody composition
#385Liquid formulation of long acting insulinotropic peptide conjugate
#386MULTISTEP FINAL FILTRATION
#387LOW ACIDIC SPECIES COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME USING DISPLACEMENT CHROMATOGRAPHY
#388Fc-region variants with modified FcRn- and protein A-binding properties
#389Polymeric IgA-type recombinant antibody and use thereof
#390Mutated immunoglobulin-binding polypeptides
#391LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV
#392Use of caprylic acid precipitation for protein purification
#393Immunoglobulin aggregate removal
#394Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#395Method for purification of monoclonal antibodies
#396WOUND FLUID ELEVATED PROTEASE ENZYME INHIBITION THROUGH CAMELID BLOOD PRODUCTS
#397Subcutaneous administration of anti-CD74 antibody for systemic lupus erythematosus
#398STIMULI-RESPONSIVE PROTEIN-POLYMER CONJUGATES FOR BIOSEPARATION
#399Process for the preparation of immunoglobulin G (IgG)
#400Systems and methods for the production of human polyclonal antibodies
#401METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III
#402Method for separating proteins from animal or human plasma, or plants, using a pH gradient method
#403Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural iggs
#404Immunoglobulin constant region Fc receptor binding agents
#405Method for the preparation of immunoglobulins
#406Method for the purification of antibodies
#407Adsorbent and method for producing the same
#408Antibody purification and purity monitoring
#409Immunoglobulin purification
#410Systems and methods for exchange of buffer solutions
#411Mutated immunoglobulin-binding protein
#412METHOD FOR PREPARING HUMAN PLASMA PROTEINS
#413Antibody preparations
#414Immunoglobulin purification using pre-cleaning steps
#415Process for preparation of secretory IgA and secretory IgM
#416Method of purifying an antibody
#417Ultrafiltration unit for continuous buffer or medium exchange from a protein solution
#418Chromatography method
#419Method for purifying immunoglobulin
#420Method for purifying immunoglobulin
#421Optimized method for antibody capturing by mixed mode chromatography
#422Method for purifying IgG
#423Polyvalent immunotherapeutics
#424Immunoglobulin constant region Fc receptor binding agents
#425Affinity ligands and methods relating thereto
#426On-column viral inactivation methods
#427Methods and materials for monitoring myeloma using quantitative mass spectrometry
#428Method of purifying monoclonal antibodies
#429Method for preparation of purified autoimmune antigen positive serum
#430Methods and compositions comprising purified recombinant polypeptides
#431Removal of serine proteases by treatment with finely divided silicon dioxide
#432METHOD OF MANUFACTURING INTRAVENOUS IMMUNOGLOBULIN FROM FRACTION III
#433Method for purifying recombinant protein
#434Method for separating antibody isoforms using cation exchange chromatography
#435ANTIBODY PURIFICATION
#436Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
#437Method for the clarification of high-density crude cell culture harvest
#438Solid phase for mixed-mode chromatographic purification of proteins
#439Affinity chromatography matrix
#440Protein ligand for affinity isolation matrix
#441Protease-resistant peptide ligands
#442Process for increased yield of immunoglobulin from human plasma
#443Mutated immunoglobulin-binding protein
#444Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
#445Methods of increasing protein purity using protein A based chromatography
#446Method for purifying antibody
#447Purification process for monoclonal antibodies
#448Continuous multistep process for purifying antibodies
#449Expression process
#450Purification platform for bispecific antibodies
#451Methods for purifying antibodies
#452Hydrophobic interaction protein chromatography under no-salt conditions
#453Ligands for antibody and Fc-fusion protein purification by affinity chromotography IV
#454Protein purification in the presence of nonionic organic polymers at elevated conductivity
#455Method of purifying an antibody
#456Method for refolding antibody, process for producing refolded antibody, refolded antibody, and uses thereof
#457Selective removal of a protein from a mixture of proteins using activated carbon by adjusting solution conditions
#458Purified antibody composition
#459Methods for increasing the capacity of flow-through processes
#460Purified antibody composition
#461USE OF AN ION EXCHANGE MEMBRANE TO REMOVE IMPURITIES FROM CELL-BINDING AGENT CYTOTOXIC AGENT CONJUGATES
#462Multimodal anion exchange matrices
#463Method for the production and selection of molecules comprising at least two different entities and uses thereof
#464Spider silk fusion protein structures for binding to an organic target
#465METHOD OF ISOLATING SYNAGIS(R) IN THE ABSENCE OF BENZONASE
#466Proteolytic inactivation of select proteins in bacterial extracts for improved expression
#467Methods for purification of antibodies using aliphatic alcohols
#468Immunoglobulin reduced in thrombogenic agents and preparation thereof
#469Methods for use of mixed multifunctional surfaces for reducing aggregate content in protein preparations
#470Low acidic species compositions and methods for producing and using the same using displacement chromatography
#471USE OF ALPHA-TOXIN FOR TREATING AND PREVENTING STAPHYLOCOCCUS INFECTIONS
#472Carrier for antibody purification, manufacturing method for same, and application for same
#473Method and apparatus for antibody production and purification
#474Benzimidazole compounds and their use as chromatographic ligands
#475Purified antibody composition
#476Purified antibody composition
#477Chromatography ligand
#478Antibody preparations
#479Antibody purification by cation exchange chromatography
#480Immunoglobulin constant region Fc receptor binding agents
#481Compositions comprising secretory-like immunoglobulins
#482Treatment of mucositis with immunoglobulin
#483Repebody against immunoglobulin G and uses thereof
#484FC-RECEPTOR BASED AFFINITY CHROMATOGRAPHY
#485Process for enriching IgA
#486Process for concentration of antibodies and therapeutic products thereof
#487Nucleic acid molecules encoding moonoclonal antibodies speceific for IL17F
#488Anti-drug antibody assay
#489Ion exchange membrane chromatography
#490Two-stage ultrafiltration/diafiltration
#491Removal of serine proteases by treatment with finely divided silicon dioxide
#492Method of isolating human antibodies
#493Method for removing viruses in a physiologically-active protein-containing sample
#494Method of antibody purification
#495Antibody purification and purity monitoring
#496Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
#497Methods to produce a human plasma-derived IgG preparation enriched in brain disease-related natural IgGs
#498Separation method for fucosylated antibodies
#499Method for the purification of antibodies
#500Purification of biological products by constrained cohydration chromatography
#501Method for manufacturing protein drug
#502Stable compositions of high-concentration allotype-selected antibodies for small-volume administration
#503Purification of fusion proteins
#504Composition comprising antibody that binds to domain II of HER2 and acidic variants thereof
#505Ultrafiltration concentration of allotype selected antibodies for small-volume administration
#506Method for preparing a concentrate of polyvalent immunoglobulin
#507Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
#508Process for obtaining an IgG composition through heat treatment
#509Protein for affinity-separation matrix
#510Immunoglobulin constant region FC receptor binding agents
#511Method of purifying protein
#512Method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
#513Protein purification
#514Specific sorbent for binding proteins and peptides, and separation method using the same
#515Support for affinity chromatography and method for isolating immunoglobulin
#516Antigen-binding protein directed against epitope in the CH1 domain of human IgG antibodies
#517Purified antibody composition
#518Spider silk fusion protein structures for binding to an organic target
#519Antibody purification via affinity chromatography
#520Purified antibody composition
#521Method for using light scattering in real time to directly monitor and control impurity removal in purification processes
#522Antivenom
#523High-throughput immune sequencing
#524Isolation and purification of anti-IL-13 antibodies using protein a affinity chromatography
#525Purified antibody composition
#526Purified antibody composition
#527Methods and materials for monitoring myeloma using quantitative mass spectrometry
#528Affinity chromatography matrix
#529Molecules mimicking an autoantibody idiotype and compositions containing same
#530Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such
#531Fraction I-IV-1 precipitation of immunoglobins from plasma
#532IgG stimulated remyelination of peripheral nerves
#533Optimized method for antibody capturing by mixed mode chromatography
#534Assay for detecting free light chains by capillary zone electrophoresis
#535Immunoglobulin G Fc region binding polypeptide
#536Removal of high molecular weight aggregates using hydroxyapatite chromatography
#537Removal of serine proteases by treatment with finely divided silicon dioxide
#538Mutant protein
#539REMOVAL OF VIRUCIDAL AGENTS IN MIXED MODE CHROMATOGRAPHY
#540Immunoglobulin aggregate removal
#541Solid phase for mixed-mode chromatographic purification of proteins
#542Method to produce an immunoglobulin preparation with improved yield
#543Protein capable of binding specifically to immunoglobulin, and immunoglobulin-binding affinity ligand
#544IgA-binding peptide and purification of IgA using the same
#545Removal of serine proteases by treatment with finely divided silicon dioxide
#546Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
#547ANTIBODY COMPOSITION OBTAINED BY FRACTIONATION OF PLASMA IMMUNOGLOBULINS AFFINITY CHROMATOGRAPHY ON A SAMBUCUS NIGRA AFFINITY COLUMN
#548Process for preparing an immunoglobulin composition
#549Antibody preparations
#550Anti-CDH3 antibodies and uses thereof
#551PURIFIED ANTIBODY COMPOSITION
#552Ultrafiltration concentration of allotype selected antibodies for small-volume administration
#553Process for the industrial-scale purification of gamma globulins from human plasma for industrial applications
#554IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS
#555Immunoglobulin reduced in thrombogenic agents and preparation thereof
#556Separation of protein monomers from aggregates by solid weak anion exchange support functionalized with amine moieties
#557Fusion protein binding specifically to constant region of antibody, method of preparing the fusion protein, and method of isolating antibody using the fusion protein
#558ANTIBODY PURIFICATION
#559IMMUNOGLOBULIN CLEAVAGE FRAGMENT VACCINE COMPOSITIONS
#560Purification method which prevents denaturation of an antibody
#561Chromatography purification of antibodies
#562Mutated immunoglobulin-binding protein
#563MULTISTEP FINAL FILTRATION
#564Pre-filtration adjustment of buffer solutes
#565USE OF MIXED MODE CHROMATOGRAPHY FOR THE CAPTURE AND PURIFICATION OF BASIC ANTIBODY PRODUCTS
#566SPECIFIC ANTIBODY SELECTION BY SELECTIVE ELUTION CONDITIONS
#567AFFINITY CHROMATOGRAPHY MATRIX
#568METHODS AND COMPOSITIONS FOR TREATING RESPIRATORY DISEASE-CHALLENGED ANIMALS
#569Purification method which prevents denaturation of an antibody
#570Method of weak partitioning chromatography
#571Enzymatic antibody processing
#572Methods for removing a contaminant using indigenous protein displacement ion exchange membrane chromatography
#573ANTI-ESTROGEN AND IMMUNE MODULATOR COMBINATIONS FOR TREATING BREAST CANCER
#574METHODS OF USING IMMUNOGLOBULIN AGGREGATES
#575COMPOSITIONS AND METHODS FOR DEMONSTRATING SECRETORY IMMUNE SYSTEM REGULATION OF STEROID HORMONE RESPONSIVE CANCER CELL GROWTH
#576PROTEIN PURIFICATION BY CAPRYLIC ACID (OCTANOIC ACID) PRECIPITATION
#577Affinity material
#578Method for removing viruses from high concentration monoclonal antibody solution
#579Compositions of F(ab′)antibody fragments
#580Treatment of celiac disease with IgA
#581BREAST CANCER ERADICATION PROGRAM
#582Receptor gene screening for detecting or diagnosing cancer
#583AFFINITY PURIFIED HUMAN POLYCLONAL ANTIBODIES AGAINST VIRAL, BACTERIAL AND/OR FUNGAL INFECTIONS AND METHODS OF MAKING AND USING THE SAME
#584Separation method using single polymer phase systems
#585Process for the Purification of Antibodies Using Affinity Resins Comprising Specific Ligands
#586Rapid isolation of monoclonal antibodies from animals
#587RECIPROCAL SERUM/PLASMA EXCHANGE FOR THE TREATMENT OF CANCER
#588REMOVAL OF PROTEIN AGGREGATES FROM BIOPHARMACEUTICAL PREPARATIONS USING CALCIUM PHOSPHATE SALTS
#589Method to produce an immunoglobulin preparation with improved yield
#590Method to produce an immunoglobulin preparation with improved yield
#591Removal of serine proteases by treatment with finely divided silicon dioxide
#592Chromatography ligand
#593ENHANCED CAPACITY AND PURIFICATION OF PROTEIN BY MIXED MODE CHROMATOGRAPHY IN THE PRESENCE OF AQUEOUS-SOLUBLE NONIONIC ORGANIC POLYMERS
#594AQUEOUS TWO PHASE EXTRACTION AUGMENTED PRECIPITATION PROCESS FOR PURIFICATION OF THERAPEUTIC PROTEINS
#595Immunoglobulin purification
#596METHOD FOR OBTAINING AN EXCIPIENT-FREE ANTIBODY SOLUTION
#597Two-stage ultrafiltration/diafiltration
#598Isolation and purification of anti-IL-13 antibodies using protein A affinity chromatography
#599Purification process for fragment antibodies
#600Methods of purifying anti A β antibodies